Open Access Open Access  Restricted Access Subscription or Fee Access

Iron Profile in Gestational Diabetes Mellitus

Abdul Naeem Mansoory, Afsana Sheikh, Kusum Bala Jain, Mukesh Vijayvergia, Mohammed Shadab Gouri

Abstract


Background: The precise mechanisms behind the etio-pathogenesis of gestational diabetes mellitus (GDM) are unknown. According to epidemiological evidence, GDM is linked to higher body iron reserves. Higher serum ferritin levels, which are widely employed as a marker of the body's iron store, have been observed in people with diabetes mellitus. The goal of this study was to see if this occurred in GDM women. Materials and Methods: From April 2023 to October 2023, an observational cross-sectional study was carried out. We have collected data from hospital records, diagnosed with GDM and without GDM. Using a blood sample, serum levels of ferritin, iron, total iron binding capacity (TIBC), percentage of transferrin saturation, and C-reactive protein (CRP) were determined. Results: 40 subjects, 20 women with GDM and 20 women without GDM, were observed. The serum levels of iron, ferritin, transferrin saturation, TIBC, and CRP did not differ between those with and without GDM. Significantly positive correlations between serum ferritin and serum transferrin saturation and significant negative correlations between TIBC levels and serum ferritin were found. Conclusions: Women with and without GDM did not substantially differ in terms of serum ferritin or other iron-related markers. According to the findings of this investigation, high serum ferritin levels do not appear to be beneficial as a marker for the development of GDM.

Keywords


Gestational diabetes mellitus, iron, ferritin, TIBC, transferrin saturation.

Full Text:

PDF

References


Tandon N, Anjana RM, Mohan V, Kaur T, Afshin A, Ong K, Mukhopadhyay S,Thomas N, Bhatia E, Krishnan A, Mathur P. The increasing burden of diabetes and variations among the states of India: The Global Burden of Disease Study 1990– 2016. The Lancet Global health. 2018 Dec 1;6(12): e1352-62.

Rajput, R., Yadav, Y., Nanda, S., and Rajput, M. (2013). Prevalence of gestational diabetes mellitus & associated risk factors at a tertiary care hospital in Haryana. Indian J. Med. Res. 137, 728–733.

Association, A.D. (2016). 2. Classification and Diagnosis of Diabetes. Diabetes Care 39, S13–S22.

Zhu, Y., and Zhang, C. (2016). Prevalence of Gestational Diabetes and Risk of Progression to Type 2 Diabetes: a Global Perspective. Curr. Diab. Rep. 16, 7.

Adediran, A., Gbadegesin, A., Adeyemo, T.A., Akinbami, A.A., Akanmu, A.S., Osunkalu, V., Ogbenna, A.A., and Oremosu, A. (2011). Haemoglobin and ferritin concentrations of pregnant women at term. Obstet. Med. 4, 152–155.

Dao, M.C., Sen, S., Iyer, C., Klebenov, D., and Meydani, S.N. (2013a). Obesity during pregnancy and fetal iron status: is Hepcidin the link? J. Perinatol. Off. J. Calif. Perinat. Assoc. 33, 177–181.

Finkenstedt, A., Widschwendter, A., Brasse-Lagnel, C.G., Theurl, I., Hubalek, M., Dieplinger, H., Tselepis, C., Ward, D.G., Vogel, W., and Zoller, H. (2012a). Hepcidin is correlated to soluble hemojuvelin but not to increased GDF15 during pregnancy. Blood Cells. Mol. Dis. 48, 233–237.

Gyarmati, B., Szabó, E., Szalay, B., Czuczy, N., Toldi, G., Cseh, Á., Vásárhelyi, B., and Takáts, Z. (2011a). Serum maternal hepcidin levels 3 days after delivery are higher compared to those measured at parturition. J. Obstet. Gynaecol. Res. 37, 1620–1624.

van Santen, S., Kroot, J.J.C., Zijderveld, G., Wiegerinck, E.T., Spaanderman, M.E.A., and Swinkels, D.W. (2013a). The iron regulatory hormone hepcidin is decreased in pregnancy: a prospective longitudinal study. Clin. Chem. Lab. Med. 51, 1395–1401.

Larsson, A., Palm, M., Hansson, L.-O., and Axelsson, O. (2008). Reference values for clinical chemistry tests during normal pregnancy. BJOG Int. J. Obstet. Gynaecol. 115, 874–881.

Xiao, R., Sorensen, T.K., Frederick, I.O., El-Bastawissi, A., King, I.B., Leisenring, W.M., and Williams, M.A. (2002). Maternal second- trimester serum ferritin concentrations and subsequent risk of preterm delivery. Paediatr. Perinat. Epidemiol. 16, 297–304.

Altamura, S., Kopf, S., Schmidt, J., Müdder, K., da Silva, A.R., Nawroth, P., and Muckenthaler, M.U. (2017). Uncoupled iron homeostasis in type 2 diabetes mellitus. J. Mol. Med. 95, 1387–1398. 13. Andrews, M., Soto, N., and Arredondo-Olguín, M. (2015). Association between ferritin and hepcidin levels and inflammatory status in patients with type 2 diabetes mellitus and obesity. Nutr. Burbank Los Angel. Cty. Calif 31, 51–57.

Martinelli, N., Traglia, M., Campostrini, N., Biino, G., Corbella, M., Sala, C., Busti, F., Masciullo, C., Manna, D., Previtali, S., et al. (2012). Increased Serum Hepcidin Levels in Subjects with the Metabolic Syndrome: A Population Study. PLOS ONE 7, e48250.

Amiri, F.N., Basirat, Z., Omidvar, S., Sharbatdaran, M., Tilaki, K.H., and Pouramir, M. (2013). Comparison of the serum iron, ferritin levels and total iron-binding capacity between pregnant women with and without gestational diabetes. J. Nat. Sci. Biol. Med. 4, 302–305.

Chen, X., Scholl, T.O., and Stein, T.P. (2006). Association of Elevated Serum Ferritin Levels and the Risk of Gestational Diabetes Mellitus in Pregnant Women. Diabetes Care 29, 1077–1082.

Javadian, P., Alimohamadi, S., Gharedaghi, M.H., and Hantoushzadeh, S. (2014). Gestational diabetes mellitus and iron supplement; effects on pregnancy outcome. Acta Med. Iran. 52, 385– 389.

Kataria, Y., Wu, Y., Horskjær, P. de H., Mandrup-Poulsen, T., and Ellervik, C. (2018). Iron Status and Gestational Diabetes—A Meta- Analysis. Nutrients 10.

Lao, T.T., Chan, P.L., and Tam, K.F. (2001a). Gestational diabetes mellitus in the last trimester – a feature of maternal iron excess? Diabet. Med. 18, 218–223.

Derbent, A.U., Simavli, S.A., Kaygusuz, I., Gumus, I.I., Yılmaz, S., Yıldırım, M., and Uysal, S. (2013). Serum hepcidin is associated with parameters of glucose metabolism in women with gestational diabetes mellitus. J. Matern. Fetal Neonatal Med. 26, 1112–1115.

Raza, N., Sarwar, I., Munazza, B., Ayub, M., and Suleman, M. (2011). Assessment of iron deficiency in pregnant women by determining iron status. J. Ayub Med. Coll. Abbottabad JAMC 23, 36–40.

Alizadeh, L., and Salehi, L. (2016). Is Routine Iron Supplementation Necessary in Pregnant Women with High Hemoglobin? Iran. Red Crescent Med. J. 18.

Kumar, A. (1999). National nutritional anaemia control programme in India. Indian J. Public Health 43, 3–5, 16.

Peña-Rosas, J.P., De-Regil, L.M., Dowswell, T., and Viteri, F.E. (2012). Daily oral iron supplementation during pregnancy. Cochrane Database Syst. Rev. 12, CD004736.

Nemeth, E., Valore, E.V., Territo, M., Schiller, G., Lichtenstein, A., and Ganz, T. (2003a). Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101, 2461–2463.




DOI: https://doi.org/10.37591/tdd.v10i2.1341

Refbacks

  • There are currently no refbacks.


Copyright (c) 2023 Trends in Drug Delivery